Follow
Shilpa Chitnis. MD, Ph.D., FAAN.
Shilpa Chitnis. MD, Ph.D., FAAN.
Professor of Neurology
Verified email at utsouthwestern.edu
Title
Cited by
Cited by
Year
History, applications, and mechanisms of deep brain stimulation
S Miocinovic, S Somayajula, S Chitnis, JL Vitek
JAMA neurology 70 (2), 163-171, 2013
6512013
Automated gait and balance parameters diagnose and correlate with severity in Parkinson disease
DC Dewey, S Miocinovic, I Bernstein, P Khemani, RB Dewey III, R Querry, ...
Journal of the neurological sciences 345 (1-2), 131-138, 2014
1022014
Psychosis in Parkinson disease: a review of etiology, phenomenology, and management
N Samudra, N Patel, KB Womack, P Khemani, S Chitnis
Drugs & aging 33, 855-863, 2016
752016
Outcomes, management, and potential mechanisms of interleaving deep brain stimulation settings
S Miocinovic, P Khemani, R Whiddon, P Zeilman, D Martinez-Ramirez, ...
Parkinsonism & related disorders 20 (12), 1434-1437, 2014
672014
The effect of SPEAK OUT! and The LOUD Crowd on dysarthria due to Parkinson's disease
A Behrman, J Cody, S Elandary, P Flom, S Chitnis
American Journal of Speech-Language Pathology 29 (3), 1448-1465, 2020
522020
Deep brain stimulation and sleep-wake disturbances in Parkinson disease: a review
VD Sharma, S Sengupta, S Chitnis, AW Amara
Frontiers in neurology 9, 697, 2018
492018
Comparison of globus pallidus interna and subthalamic nucleus in deep brain stimulation for Parkinson disease: an institutional experience and review
S Mirza, U Yazdani, R Dewey Iii, N Patel, RB Dewey Jr, S Miocinovic, ...
Parkinson’s Disease 2017 (1), 3410820, 2017
422017
Advanced MRI techniques for transcranial high intensity focused ultrasound targeting
BR Shah, VT Lehman, TJ Kaufmann, D Blezek, J Waugh, D Imphean, ...
Brain 143 (9), 2664-2672, 2020
412020
Rivastigmine in Parkinson's disease dementia
S Chitnis, J Rao
Expert opinion on drug metabolism & toxicology 5 (8), 941-955, 2009
372009
Zidovudine (AZT) treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha (GM-CSFRα) gene expression in murine bone marrow cells
S Chitnis, D Mondal, KC Agrawal
Life sciences 71 (8), 967-978, 2002
362002
The effects of the “SPEAK OUT!®” and “LOUD Crowd®” voice programs for Parkinson disease
JS Levitt, S Chitnis, D Walker-Batson
International Journal of Health Sciences 3 (2), 13-19, 2015
322015
Patient perceptions and knowledge of Parkinson's disease and treatment (KnowPD)
MR Salinas, EJ Chambers, T Ho, P Khemani, DWM Olson, S Stutzman, ...
Clinical Parkinsonism & Related Disorders 3, 100038, 2020
212020
Dysarthria treatment for Parkinson’s disease: one-year follow-up of SPEAK OUT!® with the LOUD Crowd®
A Behrman, J Cody, S Chitnis, S Elandary
Logopedics Phoniatrics Vocology 47 (4), 271-278, 2022
182022
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis
JT Tossberg, PS Crooke, MA Henderson, S Sriram, D Mrelashvili, ...
Genes & Immunity 13 (2), 146-154, 2012
142012
Early-onset Parkinson's disease: An assessment of unmet psychosocial needs
B McDaniels, I Subramanian, S Kurian, S Chitnis
Parkinsonism & Related Disorders 110, 105395, 2023
122023
Cystic lesions as a rare complication of deep brain stimulation
VD Sharma, AR Bona, A Mantovani, S Miocinovic, P Khemani, ...
Movement disorders clinical practice 3 (1), 87-90, 2016
122016
Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment
S Chitnis
Neurologic clinics 26 (3), 29-44, 2008
92008
Ropinirole treatment for restless legs syndrome
S Chitnis
Expert Opinion on Drug Metabolism & Toxicology 4 (5), 655-664, 2008
82008
Lack of accredited clinical training in movement disorders in Europe, Egypt, and Tunisia
G Tamas, M Fabbri, C Falup-Pecurariu, T Teodoro, MM Kurtis, R Aliyev, ...
Journal of Parkinson's disease 10 (4), 1833-1843, 2020
72020
Tetrabenazine in Huntington's disease chorea
S Chitnis, CA Karunapuzha
Clinical Medicine. Therapeutics 1, CMT. S2134, 2009
72009
The system can't perform the operation now. Try again later.
Articles 1–20